UGT1A1 regulatory variant with potential effect on efficacy of HIV and cancer drugs commonly prescribed in South Africa
dc.citation.doi | 10.2217/PGS-2021-0062 | |
dc.citation.epage | 972 | |
dc.citation.spage | 963 | |
dc.contributor.author | Jenny Mathew | |
dc.contributor.author | Phelelani Mpangase | |
dc.contributor.author | Dhriti Sengupta | |
dc.contributor.author | S Kwenda | |
dc.contributor.author | Demetra Mavri-Damelin | |
dc.contributor.author | Michele Ramsay | |
dc.date.accessioned | 2023-04-13T14:30:43Z | |
dc.date.available | 2023-04-13T14:30:43Z | |
dc.identifier.citation | WOS | |
dc.identifier.issn | 1462-2416 | |
dc.identifier.uri | https://hdl.handle.net/10539/35181 | |
dc.journal.title | PHARMACOGENOMICS | |
dc.journal.volume | 22 | |
dc.title | UGT1A1 regulatory variant with potential effect on efficacy of HIV and cancer drugs commonly prescribed in South Africa |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal.pdf
- Size:
- 496.82 KB
- Format:
- Adobe Portable Document Format
- Description:
- Journal